Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
November 5, 2019 Off

The World Market for Red Biotechnology – Global Industry Analysis 2017-2019 & Forecast to 2027 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Red Biotechnology Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027” report has been added…

November 5, 2019 Off

Aerie Pharmaceuticals Announces Positive Topline Results for Netarsudil Ophthalmic Solution in Phase 2 Study Conducted in Japan

By BusinessWire

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies…

November 5, 2019 Off

Relay Therapeutics Appoints Human Resources Expert Andy Porter as Executive Vice President and Chief People Officer

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–#oncology—Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, today announced the appointment…

November 5, 2019 Off

Pivotal Data Presented at ObesityWeek 2019 Highlight the Therapeutic Benefits of PlenityTM in Adults with Obesity and Underscore its Safety and Efficacy in Lower-BMI Overweight Adults

By BusinessWire

Plenity-treated adults achieving a BMI of <27 lost an average of 13.5% of their weight with the rate of weight…

November 5, 2019 Off

Global $6.7 Bn Ovarian Cancer Opportunity Analysis and Forecasts to 2028 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Ovarian Cancer: Opportunity Analysis and Forecasts to 2028” report has been added to ResearchAndMarkets.com’s offering. Ovarian Cancer: Opportunity…

November 5, 2019 Off

Almirall Makes Shift to Specialty Medicine with Veeva CRM

By BusinessWire

Spain’s leading pharmaceutical company drives seamless customer engagement across multiple stakeholders using face-to-face, email, and web BARCELONA, Spain–(BUSINESS WIRE)–Veeva Systems…

November 5, 2019 Off

Engitix Receives a Golden Ticket to LabCentral from Takeda to Advance Fibrosis and Solid Tumour Research

By BusinessWire

Golden Ticket includes one year of lab bench space at Cambridge, MA-based shared laboratory and office space LONDON–(BUSINESS WIRE)–Engitix Ltd…

November 5, 2019 Off

Takeda Continues Strategic Divestitures With Sale of Select OTC and Non-Core Assets to STADA for $660 Million USD

By BusinessWire

Transaction further accelerates deleveraging Strengthens alignment of Growth & Emerging Markets Business Unit portfolio with Takeda’s global business areas OSAKA,…

November 5, 2019 Off

Ipsen Appoints Howard Mayer, M.D. as Executive Vice President and Head of Research and Development

By BusinessWire

PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced the appointment of Dr. Howard Mayer as Executive Vice President…

November 5, 2019 Off

Proposed reclassification of Ipsen shares held by Mayroy

By BusinessWire

Mayroy files a request with the AMF for a waiver to the obligation to file a public offer PARIS–(BUSINESS WIRE)–Regulatory…

Posts pagination

Previous 1 … 5,371 5,372 5,373 … 6,212 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector

December 18, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine